This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
9 MAR, 2023
The next frontier in oligonucleotide synthesis is the direct synthesis of gene-length sequences.
Ansa synthesized a 1005 base long oligonucleotide with industry-leading accuracy.
Ansa will be initiating an Early Access Program for clonal synthetic genes in April 2023 to help researchers obtain sequences that have been difficult to synthesize
“The 1005 base sequence encodes a key part of an AAV vector used for gene therapy development and contains complex features, including strong secondary structures and high GC content, which are extremely challenging to synthesize using conventional methods that require assembly of shorter oligonucleotides.”
Reference: https://ansabio.com/news